A detailed history of S.A. Mason LLC transactions in Viatris Inc stock. As of the latest transaction made, S.A. Mason LLC holds 2,850 shares of VTRS stock, worth $30,238. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,850
Previous 2,849 0.04%
Holding current value
$30,238
Previous $33,000 6.06%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$11.32 - $13.37 $11 - $13
1 Added 0.04%
2,850 $35,000
Q3 2024

Oct 25, 2024

BUY
$10.32 - $12.13 $20 - $24
2 Added 0.07%
2,849 $33,000
Q2 2024

Jul 10, 2024

SELL
$10.05 - $12.02 $1,989 - $2,379
-198 Reduced 6.5%
2,847 $30,000
Q1 2024

Apr 15, 2024

BUY
$11.27 - $13.53 $22 - $27
2 Added 0.07%
3,045 $36,000
Q4 2023

Jan 17, 2024

SELL
$8.77 - $10.85 $3,657 - $4,524
-417 Reduced 12.05%
3,043 $32,000
Q3 2023

Oct 13, 2023

BUY
$9.59 - $11.35 $9,628 - $11,395
1,004 Added 40.88%
3,460 $34,000
Q1 2023

May 10, 2023

BUY
$9.2 - $12.26 $73 - $98
8 Added 0.33%
2,456 $23,000
Q4 2022

Jan 10, 2023

BUY
$8.72 - $11.56 $17 - $23
2 Added 0.08%
2,448 $0
Q3 2022

Oct 20, 2022

SELL
$8.48 - $11.13 $1,187 - $1,558
-140 Reduced 5.41%
2,446 $21,000
Q2 2022

Jul 07, 2022

SELL
$9.95 - $12.27 $268 - $331
-27 Reduced 1.03%
2,586 $27,000
Q1 2022

May 12, 2022

SELL
$9.81 - $15.4 $3,874 - $6,083
-395 Reduced 13.13%
2,613 $28,000
Q4 2021

Jan 04, 2022

BUY
$12.09 - $14.68 $3,361 - $4,081
278 Added 10.18%
3,008 $41,000
Q3 2021

Oct 12, 2021

BUY
$13.25 - $15.13 $9,858 - $11,256
744 Added 37.46%
2,730 $37,000
Q1 2021

Apr 20, 2021

BUY
$13.59 - $18.54 $5,436 - $7,416
400 Added 25.22%
1,986 $28,000
Q4 2020

Feb 02, 2021

BUY
$14.3 - $18.74 $22,679 - $29,721
1,586 New
1,586 $30,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track S.A. Mason LLC Portfolio

Follow S.A. Mason LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.A. Mason LLC with notifications on news.